AGL vs. PRVA, PINC, SHC, PGNY, SYNH, VMD, CO, BHG, OTRK, and MRAI
Should you be buying agilon health stock or one of its competitors? The main competitors of agilon health include Privia Health Group (PRVA), Premier (PINC), Sotera Health (SHC), Progyny (PGNY), Syneos Health (SYNH), Viemed Healthcare (VMD), Global Cord Blood (CO), Bright Health Group (BHG), Ontrak (OTRK), and Marpai (MRAI).
Privia Health Group (NASDAQ:PRVA) and agilon health (NYSE:AGL) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, community ranking, risk and media sentiment.
Privia Health Group received 8 more outperform votes than agilon health when rated by MarketBeat users. Likewise, 73.08% of users gave Privia Health Group an outperform vote while only 51.04% of users gave agilon health an outperform vote.
Privia Health Group has higher earnings, but lower revenue than agilon health. agilon health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.
94.5% of Privia Health Group shares are owned by institutional investors. 14.2% of Privia Health Group shares are owned by company insiders. Comparatively, 3.2% of agilon health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Privia Health Group has a net margin of 1.11% compared to Privia Health Group's net margin of -5.67%. agilon health's return on equity of 3.13% beat Privia Health Group's return on equity.
Privia Health Group currently has a consensus price target of $24.92, indicating a potential upside of 43.48%. agilon health has a consensus price target of $9.03, indicating a potential upside of 43.39%. Given agilon health's stronger consensus rating and higher possible upside, research analysts plainly believe Privia Health Group is more favorable than agilon health.
Privia Health Group has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. Comparatively, agilon health has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500.
In the previous week, Privia Health Group had 6 more articles in the media than agilon health. MarketBeat recorded 16 mentions for Privia Health Group and 10 mentions for agilon health. agilon health's average media sentiment score of 0.93 beat Privia Health Group's score of 0.49 indicating that Privia Health Group is being referred to more favorably in the media.
Summary
Privia Health Group beats agilon health on 18 of the 19 factors compared between the two stocks.
Get agilon health News Delivered to You Automatically
Sign up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
agilon health Competitors List
Related Companies and Tools
